Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CEACAM5-targeted antibody-drug conjugate
Welcome,
Profile
Billing
Logout
Companies
Products
Products
Diseases
Trials
News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
tusamitamab ravtansine
(SAR408701) / Sanofi, AbbVie
labetuzumab govitecan
(IMMU-130) / Gilead
precemtabart tocentecan
(M9140) / EMD Serono
A2B530
/ A2 Biotherap
EBC-129
/ A*Star, National Cancer Centre Singapore
PF-08046050
/ Sanofi, Pfizer
